BUY Dr. Lal Path Labs Ltd. — Emkay Global
Dr. Lal Path Labs share price target & all analyst calls
byEmkay GlobalHorizon: NA (inferred 1 year)1 May 2026via Institutional / Brokerage Research
Entry₹1,390.4Inferred
Stop lossNot given
Exit₹1,74016 Jun 2026, 12:06 pm
Follow Emkay Global for new calls(64% target hit, 377 closed calls)Get alertsWatch LALPATHLAB for new buy/sell callsGet alertsSee 3 active Long-term calls on LALPATHLABSee 274 active Long-term picks this week
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
2 supporting1 neutral0 opposing
Supports the BUY call (2)
Nothing found in this tip’s window yet.
Neutral / worth noting (1)
Nothing found in this tip’s window yet.
Weighs against the BUY call (0)
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Dr. Lal Path Labs
- BUY — Axis Securities12 Oct 2026 · ~1 year · target ₹2,315 · Active
- BUY — Kush Bohra9 Oct 2026 · Next day · target ₹1,990 · Target hit
- BUY — Deven Mehata, IDBI Capital Markets and Securities5 Oct 2026 · ~2 weeks · target ₹2,165 · SL hit
- BUY — Sachin Gupta5 Oct 2026 · ~2 weeks · target ₹2,100 · SL hit
- BUY — IDBI Capital1 Oct 2026 · ~3 months · target ₹2,195 · SL hit
More from Emkay Global
- BUY Cyient23 Oct 2026 · ~1 year · target ₹1,300 · Active
- BUY Eternal22 Oct 2026 · ~1 year · target ₹420 · Active
- BUY Piramal Finance21 Oct 2026 · ~1 year · target ₹2,100 · Active
- BUY Urban Company19 Oct 2026 · ~1 year · target ₹200 · Active
- BUY ICICI Bank19 Oct 2026 · ~1 year · target ₹1,785 · Active

